Exact Therapeutics AS (OSL:EXTX) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Days Payable?

Exact Therapeutics AS's average Accounts Payable for the six months ended in Jun. 2024 was kr7.32 Mil. Exact Therapeutics AS's Cost of Goods Sold for the six months ended in Jun. 2024 was kr0.00 Mil.

The historical rank and industry rank for Exact Therapeutics AS's Days Payable or its related term are showing as below:

OSL:EXTX's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

Exact Therapeutics AS's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Exact Therapeutics AS Days Payable Historical Data

The historical data trend for Exact Therapeutics AS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Days Payable Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Exact Therapeutics AS's Days Payable

For the Biotechnology subindustry, Exact Therapeutics AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's Days Payable distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's Days Payable falls into.

Exact Therapeutics AS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Exact Therapeutics AS's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (9.551	+	7.205)	/	2 )	/	0	*	365
=	8.378					/	0	*	365
=	N/A

Exact Therapeutics AS's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (7.205	+	7.427)	/	2 )	/	0	*	365 / 2
=	7.316					/	0	*	365 / 2
=	N/A

Exact Therapeutics AS Days Payable Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing Acoustic Cluster Therapy (ACT), a promising non-invasive precision health technology for targeted enhancement of therapeutics. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS Headlines

No Headlines